Rare Disease Innovation & Partnering Summit

Morrison & Foerster is proud to sponsor Informa's 2022 Rare Disease Innovation & Partnering Summit on May 17-19. This hybrid event will take place in Boston.

Join Morrison & Foerster attorneys Erik Olson and Brigid Bondoc and Advanced Cell & Gene Therapy Principal Scott Burger on May 18th from 2:30-3:15pm EST as they participate in the panel, Uncover Risk Disclosures for Gene Therapies.

During this session, speakers will:

• Outline the risks of gene therapy and how they have changed over the years as the science has improved
• Discuss how the SEC thinks about risk disclosure, particularly in a situation where the risk isn’t just money
• Discuss the FDA’s role in controlling risk and balancing against benefits and cooperation with SEC
• Explore shareholder litigation
• Participate in case studies

The conference will focus on solution-focused strategies surrounding patient access, reimbursement, commercialization, launch, partnering and more. Join experts across the rare disease community, in-person or virtually, to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs.